AiBotThe Department of Defense has taken a significant step towards addressing the health and wellbeing of its service members. Secretary of War Pete Hegseth announced on Tuesday that the Pentagon will begin annual testosterone-deficiency screenings for service members aged 30 and older. Additionally, troops younger than 30 may opt in voluntarily for the screenings.
According to a statement released by the Pentagon, the decision to introduce these screenings is part of an ongoing effort to prioritize the health and readiness of the US military. Testosterone-deficiency syndrome, also known as hypogonadism, is a condition that affects men’s hormone production, leading to symptoms such as fatigue, decreased libido, and mood changes. The Pentagon cited data suggesting that hypogonadism affects an estimated 15-20% of active-duty service members.
“We recognize that our service members are at the pinnacle of their physical and mental resilience, and it is our duty to support and protect their health,” Secretary Hegseth stated. “These screenings will enable us to better identify and address any health issues that could impact their performance and overall wellbeing.”
Testosterone levels naturally decline with age, but the condition can also be exacerbated by military service, exposure to certain chemicals, and certain medical conditions. By identifying and treating hypogonadism, the Pentagon hopes to mitigate its effects and promote optimal health and performance among its service members.
The new policy applies to all active-duty service members aged 30 and older, with the exception of those who have previously undergone testosterone replacement therapy or have been diagnosed with hypogonadism. In these cases, service members will be exempt from mandatory screenings.
Troops under the age of 30 are permitted to opt-in for the screenings on a voluntary basis. Healthcare providers within the Defense Health Agency will be responsible for conducting the screenings, utilizing a standardized assessment protocol to evaluate each service member’s testosterone levels and overall health.
While some critics argue that mandatory screenings could raise concerns about individual freedom and the potential stigma associated with hypogonadism, proponents of the policy argue that it is essential for maintaining the military’s overall health and readiness.
“This is a common-sense step that we’re taking to support our service members’ health and wellbeing,” said Dr. Mark Kelley, a spokesperson for the Defense Health Agency. “We believe that these screenings will ultimately contribute to a more resilient and effective military force.”
The new policy will take effect in January 2027, with full implementation expected to be completed by the end of 2028. As for the financial implications of these screenings, the Pentagon has allocated an estimated $20 million in appropriations for the purpose of conducting these assessments and treating associated medical conditions.